SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-040930
Filing Date
2011-04-28
Accepted
2011-04-28 16:06:02
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c15820e10vq.htm 10-Q 403832
2 EX-31.1 SECTION 302 CERTIFICATION OF CEO c15820exv31w1.htm EX-31.1 5801
3 EX-31.2 SECTION 302 CERTIFICATION OF CFO c15820exv31w2.htm EX-31.2 5794
4 EX-32.1 SECTION 906 CERTIFICATION OF CEO c15820exv32w1.htm EX-32.1 3415
5 EX-32.2 SECTION 906 CERTIFICATION OF CFO c15820exv32w2.htm EX-32.2 3419
  Complete submission text file 0000950123-11-040930.txt   423342
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 11788465
SIC: 2834 Pharmaceutical Preparations